The Journey from Melanocyte to Melanoma: Discussion of Therapeutical Implications

The presentation discusses the intricate journey of melanocytes transforming into melanoma, outlining therapeutic implications along the way. It starts with a historical overview of melanocytic neoplasia classification, highlighting two main subtypes: high cumulative sun damage (CSD) and low CSD melanomas. High CSD melanomas typically arise on chronically sun-exposed skin, have a high mutation burden, and share distinct driver mutations such as mutations in the NRAS gene. In contrast, low CSD melanomas appear on intermittently sun-exposed areas and exhibit a different mutation pattern, prominently featuring BRAF V600E mutations. The discussion includes the evolutionary patterns of melanoma, tracing their origins from precursor lesions like common nevi or dysplastic nevi. It reveals that even in seemingly normal skin, oncogenic mutations can exist, suggesting multiple pathways to malignant transformation, including direct mutations from UV exposure. The presentation also contrasts acral melanomas with cutaneous melanomas, identifying distinct genetic signatures and evolution patterns, characterized by complex copy number alterations known as 'hailstorms.' This underscores the importance of genetic testing in treatment decisions, as specific mutations influence responsiveness to targeted therapies. Ultimately, the speaker emphasizes that the order and nature of mutations significantly dictate the melanoma's progression and its therapeutic approach.